| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.03▼ | 4.03▼ | 4.05▼ | 4.05▼ | 4.39▼ |
| MA10 | 4.04▼ | 3.99▲ | 4.00▲ | 4.32▼ | 4.18▼ |
| MA20 | 3.99▲ | 4.04▼ | 4.05▼ | 4.50▼ | 3.98▲ |
| MA50 | 4.08▼ | 4.12▼ | 4.30▼ | 4.19▼ | 3.23▲ |
| MA100 | 4.08▼ | 4.45▼ | 4.50▼ | 3.81▲ | N/A |
| MA200 | 4.38▼ | 4.47▼ | 4.45▼ | 3.09▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.007▲ | 0.010▲ | 0.020▲ | -0.099▼ | 0.047▲ |
| RSI | 49.332▼ | 47.391▼ | 45.607▼ | 43.952▼ | 50.815▲ |
| STOCH | 37.065 | 58.024 | 47.162 | 22.160 | 32.789 |
| WILL %R | -44.898 | -55.738 | -55.738 | -77.899▼ | -75.175▼ |
| CCI | 9.987 | 2.313 | 1.014 | -82.801 | -4.651 |
|
Wednesday, January 21, 2026 12:00 AM
SAN DIEGO, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV) (Artiva), a clinical-stage biotechnology company whose mission is to develop effective, safe and accessible ...
|
|
Tuesday, January 20, 2026 04:00 PM
SAN DIEGO, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV) (Artiva), a clinical-stage biotechnology company whose mission is to develop effective, safe and accessible ...
|
|
Thursday, January 15, 2026 12:02 PM
Artiva Biotherapeutics is working on NK cell-based immunotherapy to treat autoimmune disease. Their lead project is an unmodified, preserved NK product that seeks to address challenges posed for CAR T ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 05/02/26 | 4.135 | 4.135 | 4.005 | 4.025 | 70,235 |
| 04/02/26 | 4.20 | 4.20 | 3.85 | 4.02 | 121,031 |
| 03/02/26 | 4.19 | 4.23 | 4.01 | 4.14 | 173,394 |
| 02/02/26 | 3.84 | 4.24 | 3.84 | 4.18 | 219,427 |
| 30/01/26 | 4.17 | 4.22 | 3.72 | 3.89 | 338,697 |
| 29/01/26 | 4.43 | 4.53 | 4.10 | 4.15 | 237,036 |
| 28/01/26 | 4.93 | 4.93 | 4.47 | 4.47 | 167,747 |
| 27/01/26 | 4.68 | 4.93 | 4.50 | 4.85 | 167,303 |
| 26/01/26 | 4.80 | 4.83 | 4.62 | 4.68 | 77,792 |
| 23/01/26 | 4.98 | 4.9809 | 4.7502 | 4.78 | 174,843 |
|
|
||||
|
|
||||
|
|